Prof. Paul J. Rutgeerts PhD

• 
  www.clinicaladvances.com/index.php/our_publications/gas - [Cached Version]
  Published on: 3/22/2008    Last Visited: 3/22/2008  

  Paul Rutgeerts, MD Katholieke Universiteit Leuven

• 
  www.thepharmyard.com/shop/product.php?xProd=1951&jssCar - [Cached Version]
  Published on: 12/1/2007    Last Visited: 8/6/2008  

  Gert Van Assche, Séverine Vermeire and Paul Rutgeerts, Division of Gastroenterology, University of Leuven, Leuven, Belgium

• 
  imedex.com/calendars/gastroenterology.asp - [Cached Version]
  Last Visited: 6/22/2008  

  Co-Moderators: Richard P. MacDermott, MD and Paul Rutgeerts, MD, PhD
  ...
  Co-Moderators: Richard P. MacDermott, MD and Paul Rutgeerts, MD

• 
  www.holders.com/holdrs/main/index.asp?Description=Bioge - [Cached Version]
  Published on: 5/23/2001    Last Visited: 7/27/2001  

  "Many existing therapies have problematic side-effects, or have questions concerning safety with long-term use; therefore, other therapies are needed to treat this disease," said the study's lead investigator, Paul Rutgeerts, MD, PhD, FRCP, Professor of Medicine and Head of the Department of Endoscopy, Universitaire Ziekenhuizen Leuven, Belgium."The Phase II data are exciting because they show, for the first time, that this novel humanized monoclonal antibody may provide an effective treatment to induce remission and maintenance of Crohn's Disease.We look forward to Phase III studies to learn more about this promising new drug."
  
  Approximately one million people worldwide have Crohn's Disease, a chronic inflammatory relapsing-remitting disease of the GI tract, which commonly affects both men and women.The onset of disease is in young adults.The disease usually causes diarrhea, crampy abdominal pain, often fever, and at times rectal bleeding.

• 
  www.accessibility.com.au/news/management-of-inflammator - [Cached Version]
  Published on: 7/29/2007    Last Visited: 10/7/2008  

  Co-chairs of the conference were Stephen B. Hanauer, MD, professor of medicine and clinical pharmacology at the University of Chicago, and Paul Rutgeerts, MD, AGAF, professor of medicine, University Hospital Gasthuisberg, Belgium.

• 
  www.celltech-group.com/media_centre/2498.htm - [Cached Version]
  Published on: 9/15/2006    Last Visited: 2/7/2008  

  Brussels, 15 September 2006 - UCB announced today the creation of the Chair in Management of Inflammatory Bowel Disease to support the research of Professor Severine Vermeire and Professor Paul Rutgeerts of the division of Gastroenterology of the university hospital at the Katholieke Universiteit Leuven (KUL).

• 
  www.ucbpharma.com/news/newsdetail?det=1075593 - [Cached Version]
  Published on: 9/15/2006    Last Visited: 5/8/2009  

  Brussels, 15 September 2006 - UCB announced today the creation of the Chair in Management of Inflammatory Bowel Disease to support the research of Professor Severine Vermeire and Professor Paul Rutgeerts of the division of Gastroenterology of the university hospital at the Katholieke Universiteit Leuven (KUL).

• 
  www.holdrs.com/holdrs/main/index.asp?Description=Biogen - [Cached Version]
  Published on: 5/23/2001    Last Visited: 5/28/2001  

  Many existing therapies have problematic side-effects , or have questions concerning safety with long-term use ; therefore , other therapies are needed to treat this disease , said the study's lead investigator , Paul Rutgeerts , MD , PhD , FRCP , Professor of Medicine and Head of the Department of Endoscopy , Universitaire Ziekenhuizen Leuven , Belgium.The Phase II data are exciting because they show , for the first time , that this novel humanized monoclonal antibody may provide an effective treatment to induce remission and maintenance of Crohn's Disease.We look forward to Phase III studies to learn more about this promising new drug..
  
  Approximately one million people worldwide have Crohn's Disease , a chronic inflammatory relapsing-remitting disease of the GI tract , which commonly affects both men and women.The onset of disease is in young adults.The disease usually causes diarrhea , crampy abdominal pain , often fever , and at times rectal bleeding.

• 
  imedex.com/announcements/279.asp?utm_source=site_upperr - [Cached Version]
  Published on: 12/24/2007    Last Visited: 12/25/2007  

  Paul Rutgeerts, MD, PhD, FRCP
  ...
  Paul Rutgeerts, MD, PhD
  ...
  Paul Rutgeerts, MD, PhD, FRCP
  ...
  Richard P. MacDermott, MD and Paul Rutgeerts, MD, PhD, FRCP
  ...
  Moderator: Paul Rutgeerts, MD, PhD, FRCP
  ...
  Professor Paul Rutgeerts
  ...
  Richard P. MacDermott, MD and Paul Rutgeerts, MD, PhD, FRCP
  ...
  Paul J. Rutgeerts, MD, PhD, FRCP
  ...
  Paul Rutgeerts, MD, PhD, FRCP
  ...
  Paul Rutgeerts, MD, PhD, FRCP

• 
  www.clingastrotext.com/authors.cfm - [Cached Version]
  Published on: 4/16/2008    Last Visited: 4/16/2008  

  Paul Rutgeerts, MD, PhD, FRCPProfessor of Medicine

Page:  1 2 3 4 5